These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6873872)

  • 1. The effects of intravenous and oral cimetidine in primary hyperparathyroidism.
    Wiske PS; Epstein S; Norton JA; Bell NH; Johnston CC
    Horm Metab Res; 1983 May; 15(5):245-8. PubMed ID: 6873872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cimetidine treatment of azotemic secondary hyperparathyroidism.
    Robinson MF; Johnson WJ; Heath H
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1206-9. PubMed ID: 6281294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.
    Maung HM; Elangovan L; Frazão JM; Bower JD; Kelley BJ; Acchiardo SR; Rodriguez HJ; Norris KC; Sigala JF; Rutkowski M; Robertson JA; Goodman WG; Levine BS; Chesney RW; Mazess RB; Kyllo DM; Douglass LL; Bishop CW; Coburn JW
    Am J Kidney Dis; 2001 Mar; 37(3):532-43. PubMed ID: 11228177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between changes in immunoreactive parathormone and its biological indices induced by cimetidine in primary hyperparathyroidism.
    van der Velden PC; Fischer HR; Hackeng WH; Schopman W; Koorevaar G; den Ottolander GJ; Silberbusch J
    Acta Med Scand; 1981; 210(6):467-70. PubMed ID: 6277160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure.
    Panichi V; Andreini B; De Pietro S; Migliori M; Taccola D; Giovannini L; Ferdeghini M; Palla R
    Clin Nephrol; 1998 Apr; 49(4):245-50. PubMed ID: 9582556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intravenous administration of cimetidine on renal excretion of calcium, phosphates, magnesium and adenosine cyclic monophosphate].
    Głuszek J; Skołuda A; Pupek-Musialik D
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):817-9. PubMed ID: 1965742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs.
    Jacob AI; Canterbury JM; Gavellas G; Lambert PW; Bourgoignie JJ
    J Clin Invest; 1981 Jun; 67(6):1753-60. PubMed ID: 7240419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperparathyroid crisis reviewed: a role for parenteral cimetidine?
    Sherwood JK; Garcia M; Ackroyd FW; Glick H; Minervini D; Goldstone RJ
    Am Surg; 1986 Jun; 52(6):320-32. PubMed ID: 3521423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cimetidine on serum calcium and parathyroid hormone levels in primary hyperparathyroidism.
    Fisken RA; Wilkinson R; Heath DA
    Br J Clin Pharmacol; 1982 Nov; 14(5):701-5. PubMed ID: 7138750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cimetidine treatment of primary hyperparathyroidism].
    Caron P; Gaillard J; Barousse C; Bouissou H; Louvet JP; Boulard C
    Ann Med Interne (Paris); 1984; 135(1):12-5. PubMed ID: 6322636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1).
    Robinson MF; Hayles AB; Heath H
    J Clin Endocrinol Metab; 1980 Oct; 51(4):912-4. PubMed ID: 6106649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism.
    Sotsiou FC; Singhellakis PN; Nikou AD; Pappas AD; Vambouka C; Sklivagou NG; Ikkos DG
    J Pathol; 1987 Apr; 151(4):271-8. PubMed ID: 3585586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine and hyperparathyroidism.
    Palmer FJ; Sawyers TM; Wierzbinski SJ
    N Engl J Med; 1980 Mar; 302(12):692. PubMed ID: 7354770
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
    Kinyamu HK; Gallagher JC; Petranick KM; Ryschon KL
    J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
    Grekas D; Balaskas E; Kampouris H; Benos A; Konstantinou A; Sioullis A; Tourkantonis A
    Clin Nephrol; 1999 Sep; 52(3):167-71. PubMed ID: 10499312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.